NDC 60505-4791-01 - Cladribine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 60505-4791
- Requested NDC
- 60505-4791-01
- Package NDCs from labels
- 60505-4791-4, 60505-4791-5, 60505-4791-6, 60505-4791-7, 60505-4791-8, 60505-4791-9, 60505-4791-1, 60505-4791-01
- Manufacturer
- Apotex Corp.
- Effective date
- 2026-06-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Cladribine - Apotex Corp. | Apotex Corp. | 2026-06-08 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 60505-4791-1 | Cladribine | 10 in 1 CARTON | TABLET | 10 | 3 | |
| 60505-4791-4 | Cladribine | 4 in 1 CARTON | TABLET | 4 | 3 | |
| 60505-4791-5 | Cladribine | 5 in 1 CARTON | TABLET | 5 | 3 | |
| 60505-4791-6 | Cladribine | 6 in 1 CARTON | TABLET | 6 | 3 | |
| 60505-4791-7 | Cladribine | 7 in 1 CARTON | TABLET | 7 | 3 | |
| 60505-4791-8 | Cladribine | 8 in 1 CARTON | TABLET | 8 | 3 | |
| 60505-4791-9 | Cladribine | 9 in 1 CARTON | TABLET | 9 | 3 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 60505-4791-1 | EA - Each | 60505-4791 | 212d5c31-e7cf-4f67-a394-219da336a477 | 1 | 2025-12-16 |
| 60505-4791-4 | EA - Each | 60505-4791 | 6423fc1f-af6a-4ccc-b16b-c15bbb29cd9e | 1 | 2025-12-16 |
| 60505-4791-5 | EA - Each | 60505-4791 | 92dfb3c9-4621-4d4d-8de9-dd4618e8321e | 1 | 2025-12-16 |
| 60505-4791-6 | EA - Each | 60505-4791 | 3614f6fc-4468-4975-b3c3-5f8e35dd7d90 | 1 | 2025-12-16 |
| 60505-4791-7 | EA - Each | 60505-4791 | ccbe0e40-8cf0-4854-ac4c-6bf5b7aab56a | 1 | 2025-12-16 |
| 60505-4791-8 | EA - Each | 60505-4791 | b5590580-ccb2-4af3-bcb6-7feb2bd99a25 | 1 | 2025-12-16 |
| 60505-4791-9 | EA - Each | 60505-4791 | efd793c4-1836-4d79-aa1a-9e5e370d4f2b | 1 | 2025-12-16 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sorbitol | SORBITOL | Baxter Healthcare Corporation | aea0b5a1-444b-4330-a3ce-26485dbbfe75 | 2019-12-31 | Warnings, Adverse reactions | 506T60A25R |
| Homeoplex D | GLYCERINUM, PHYTOLACCA DECANDRA, TARAXACUM OFFICINALE, ARSENICUM ALBUM, NITRICUM ACIDUM, NUX VOMICA, PETROLEUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, ACETYLSALICYLICUM ACIDUM, GLONOINUM, INSULINUM (SUIS), LITHIUM CARBONICUM, THYROIDINUM (SUIS), SALICYLICUM ACIDUM, ADRENOCORTICOTROPHIN, CORTISONE ACETICUM, EUGENOL, STEARYL ALCOHOL, XYLITOL, FOLLICULINUM, BENZOICUM ACIDUM, CHLORINUM, POTASSIUM SORBATE, SORBITOL, RESORCINUM, BENZYL ALCOHOL, LACTICUM ACIDUM, ISOPROPYL PALMITATE, BORICUM ACIDUM, ACETICUM ACIDUM, | Supplement Clinic, LLC. | cd6b48ab-3566-484d-8deb-15ef6f8e7e8f | 2017-11-01 | Warnings | 506T60A25R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.